Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
F. Sanz, C. Gimeno, T. Lloret, N. Tormo, M. Briones, E. Fernández, A. Cervera, M. C. Aguar, E. Chiner, J. Blanquer (Valencia, Alacant, Spain). Relationship between the presence of hypoxemia and the inflammatory response measured by C-reactive protein in bacteremic pneumococcal pneumonia. Eur Respir J 2011; 38: Suppl. 55, 2492

Member's Comments

No comment yet.

Related content which might interest you: Changes in levels of inflammatory markers (procalcitonin, C-reactive protein) in pregnant with community-acquired pneumonia (CAP) Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 C-reactive protein in community-acquired pneumonia Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia Year: 2006 C-reactive protein as severity biomarker in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2005; 26: Suppl. 49, 545s Year: 2005 Effect of corticoids on the inflammatory response measured in blood in severe community-acquired pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 461s Year: 2003 Measurements usefulness of serum C-reactive protein for management of adult community-acquired pneumonia Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator-associated pneumonia Source: Eur Respir J 2010; 35: 805-811 Year: 2010 Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia Source: Eur Respir J 2005; 25: 688-692 Year: 2005 High serum procalcitonin and C-reactive protein levels can exclude tuberculosis in community-acquired pneumonia patients with atypical presentation Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Usefulness of C-reactive protein and procalcitonin in predicting mortality in community-acquired pneumonia Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia Year: 2008 C-reactive protein (CRP) as a marker of disease severity in community acquired pneumonia patients with sepsis Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 Influence of the infecting serotype on the development of complications in bacteriemic pneumococcal pneumonia with high inflammatory response Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 Measurement of procalcitonin levels in children with bacterial or viral acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 191s Year: 2002 C-reactive protein levels in community-acquired pneumonia Source: Eur Respir J 2003; 21: 702-705 Year: 2003 Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia Source: Eur Respir J 2008; 32: 726-732 Year: 2008 Serum procalcitonin and C-reactive protein in children with community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 488s Year: 2006 Systemic cytokine levels in community-acquired pneumonia and their association with disease severity Source: Eur Respir J 2002; 20: 990-995 Year: 2002 The clinical significance of serum and bronchoalveoalr lavage inflammatory cytokine in patients with acute respiratory failure due to severe community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 347s Year: 2006 Galectin-3 reduces the severity of pneumococcal pneumonia by augmenting neutrophil function Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host Year: 2008 Comparison of inflammatory response biomarkers to predict complications in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016